ProQR Therapeutics N.V. (NASDAQ: PRQR) today announced the pricing of its previously announced underwritten public offering of 5,750,000 ordinary shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary SharesSeptember 7, 2018 4:20 AM After-Hours Stock Movers 09/05: (VRNT) (CLDR) (AVAV) Higher; (PRQR) (GWRE) (MDB) Lower (more...)5September 5, 2018 5:08 PM ProQR (PRQR) Announces Proposed $75M Public Share OfferingSeptember 5, 2018 4:02 PM ProQR Therapeutics N.V. (PRQR) PT Raised to $21 at Chardan Capital MarketsSeptember 5, 2018 2:42 PM Pre-Open Movers 09/05: (PRQR) (COUP) (VRA) Higher; (HSGX) (CAL) (NVUS) Lower (more...)September 5, 2018 9:18 AM ProQR (PRQR) Surges Amid Positive 1/2 trial of QR-110, Plans to Progress to Pivotal Phase 2/3 TrialSeptember 5, 2018 9:14 AM ProQR (PRQR) Reports Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients; Plans to Start a Phase 2/3 Pivotal TrialSeptember 5, 2018 5:49 AM